
Custom crystal commemorating the submission of a New Drug Application (NDA) to the FDA. The application for Impel NeuroPharma’s migraine treatment INP104 was supported by a Phase 3, open-label safety and tolerability trial. (20ALJ356)
Custom crystal commemorating the submission of a New Drug Application (NDA) to the FDA. The application for Impel NeuroPharma’s migraine treatment INP104 was supported by a Phase 3, open-label safety and tolerability trial. (20ALJ356)
"*" indicates required fields
With the run-up to Super Bowl LV on Sunday, February 7th, we thought we'd update a post focusing on a Lucite embedment that resulted from an earlier Super Bowl game. No, the Philadelphia Eagles won't be going to the game this year; but the Kansas...
"Custom crystal awards" is a phrase that gets searched pretty frequently online. And you'll get plenty of results if you try it yourself. But many of the results you'll get are missing some crucial information. In some cases, they're just...
Recognizing the invaluable contributions of volunteers and donors is crucial for any non-profit organization. These dedicated individuals play a pivotal role in advancing your organization's mission, often going above and beyond to support your...